Overview
Aleva Neurotherapeutics is a Swiss medical device company developing directional deep brain stimulation leads for Parkinson's disease and other movement disorders. Their directSTIM technology enables highly targeted stimulation to maximize therapeutic benefit while minimizing side effects.
More in Brain-Computer Interfaces
Latest industry news
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Target Brain Health
2026-07-11 · Funding
BrainCo Pushes to Commercialize Brain-Tech as China's BCI Ambitions Come Into Focus
2026-07-10 · Industry
FDA Clears PoNS Device for Stroke Rehabilitation, Broadening Neurostimulation's Clinical Reach
2026-07-09 · Policy
Neurovalens Wins FDA Approval for PTSD Therapy Targeting US Veterans
2026-07-08 · Policy
Company details
Category
🧠 Brain-Computer Interfaces
Location
Lausanne, Switzerland
Funding
Series C · $35M
Website
aleva-neuro.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →